BIO EUROPE 2018
CRISPR in 5 years’ time: Late-phase trials in major markets, predicts CEO
In the future, a single change in DNA could help cure cystic fibrosis, sickle cell anaemia, or haemoglobinopathies, says ERS Genomics CEO.
Archives for November 19, 2018